Cue Biopharma, Inc.
CUENASDAQHealthcare● Active
$29.08
$-0.38(-1.29%)
Market Cap$76420146
P/E Ratio—
52W High$41.42
52W Low$4.98
Cue Biopharma, Inc.（CUE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CUE · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $27.47M | $9.29M | $5.49M | $1.25M | $14.94M |
| Cost of Revenue | $0.00M | $0.00M | $38.10M | $0.00M | ($1.78M) |
| Gross Profit | $27.47M | $9.29M | ($32.61M) | $1.25M | $16.72M |
| Gross Margin %(computed) | 100.00% | 100.00% | -593.93% | 100.00% | 111.90% |
| Operating Expenses | |||||
| R&D Expenses | $37.74M | $36.30M | $40.80M | $38.58M | $41.35M |
| G&A Expenses | $16.24M | $14.59M | $16.68M | $16.17M | $17.31M |
| Total Operating Expenses | $53.99M | $50.79M | $19.54M | $54.47M | $60.43M |
| Operating Income | ($26.52M) | ($41.50M) | ($52.15M) | ($53.23M) | ($43.71M) |
| Operating Margin %(computed) | -96.56% | -446.86% | -949.89% | — | -292.56% |
| Interest Income | $0.81M | $1.62M | $2.66M | $0.93M | $0.05M |
| Interest Expense | $0.36M | $0.80M | $1.25M | $0.71M | $0.00M |
| Income Before Tax | ($26.10M) | ($40.67M) | ($50.73M) | ($53.01M) | ($43.67M) |
| Income Tax Expense | $0.50M | $0.00M | $0.00M | $0.00M | $0.49M |
| Net Income | ($26.60M) | ($40.67M) | ($50.73M) | ($53.01M) | ($44.16M) |
| Net Margin %(computed) | -96.85% | -437.97% | -924.10% | — | -295.56% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-8.40 | $-21.60 | $-33.30 | $-44.70 | $-42.30 |
| Wtd Avg Shares | 3.16M | 1.88M | 1.53M | 1.19M | 1.04M |
| EBITDA | ($22.27M) | ($37.53M) | ($46.05M) | ($50.49M) | ($45.44M) |
| EBITDA Margin %(computed) | -81.06% | -404.09% | -838.83% | — | -304.15% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Cue Biopharma, Inc.
关于Cue Biopharma, Inc.（CUE）损益表
Cue Biopharma, Inc.（CUE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CUE实现营收$0.03B，毛利润$0.03B（毛利率100.00%），净利润($0.03B)（净利率-96.85%）。
常见问题
CUE · 4 问Cue Biopharma, Inc.（CUE）2025财年营收为$0.03B，同比up195.7%。
CUE revenueCUE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09